Biodesix, Inc. (BDSX)

USD 0.61

(14.15%)

Operating Income Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual operating income in 2023 was -41.34 Million USD , up 18.23% from previous year.
  • Biodesix, Inc.'s latest quarterly operating income in 2024 Q2 was -8.17 Million USD , up 25.41% from previous quarter.
  • Biodesix, Inc. reported an annual operating income of -50.5 Million USD in 2022, down -28.46% from previous year.
  • Biodesix, Inc. reported an annual operating income of -39.31 Million USD in 2021, down -77.78% from previous year.
  • Biodesix, Inc. reported a quarterly operating income of -10.95 Million USD for 2024 Q1, down -59.99% from previous quarter.
  • Biodesix, Inc. reported a quarterly operating income of -8.59 Million USD for 2024 Q3, down -5.15% from previous quarter.

Annual Operating Income Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Operating Income of Biodesix, Inc. (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -41.34 Million USD 18.23%
2022 -50.5 Million USD -28.46%
2021 -39.31 Million USD -77.78%
2020 -22.11 Million USD 2.26%
2019 -22.62 Million USD 3.55%
2018 -23.46 Million USD 0.0%

Peer Operating Income Comparison of Biodesix, Inc.

Name Operating Income Operating Income Difference
Aspira Women's Health Inc. -18.85 Million USD -119.298%
bioAffinity Technologies, Inc. -7.97 Million USD -418.51%
Intelligent Bio Solutions Inc. -10.28 Million USD -302.035%
Standard BioTools Inc. -76.6 Million USD 46.029%
Inotiv, Inc. -81.46 Million USD 49.249%
Prenetics Global Limited -52.51 Million USD 21.274%
Neuronetics, Inc. -30.55 Million USD -35.308%
Star Equity Holdings, Inc. -4.34 Million USD -851.266%
Castle Biosciences, Inc. -67.97 Million USD 39.182%
Psychemedics Corporation -2.92 Million USD -1315.337%
RadNet, Inc. 98.69 Million USD 141.888%
Exact Sciences Corporation -215.01 Million USD 80.772%
IDEXX Laboratories, Inc. 1.09 Billion USD 103.768%
iSpecimen Inc. -11.16 Million USD -270.138%
OpGen, Inc. -15.68 Million USD -163.518%
Exagen Inc. -22.83 Million USD -81.031%
Bionano Genomics, Inc. -215.24 Million USD 80.793%
CareDx, Inc -101.9 Million USD 59.429%
Check-Cap Ltd. -19.28 Million USD -114.352%
Twist Bioscience Corporation -220.83 Million USD 81.279%
Guardant Health, Inc. -564.72 Million USD 92.679%
BioNexus Gene Lab Corp. -2.59 Million USD -1494.008%
Precipio, Inc. -7.62 Million USD -442.546%
Natera, Inc. -446.24 Million USD 90.736%
Fulgent Genetics, Inc. -72.69 Million USD 43.13%
Sera Prognostics, Inc. -39.82 Million USD -3.82%
23andMe Holding Co. -321.35 Million USD 87.135%
OPKO Health, Inc. -157.02 Million USD 73.671%
Personalis, Inc. -109.93 Million USD 62.394%
Aclaris Therapeutics, Inc. -97.35 Million USD 57.536%
Applied DNA Sciences, Inc. -10.95 Million USD -277.439%
T2 Biosystems, Inc. -49.66 Million USD 16.757%
Neogen Corporation 58.66 Million USD 170.474%
Myriad Genetics, Inc. -123.7 Million USD 66.579%
ICON Public Limited Company 956.15 Million USD 104.324%
NeoGenomics, Inc. -107.73 Million USD 61.627%
Star Equity Holdings, Inc. -4.34 Million USD -851.266%
MDxHealth SA -27.32 Million USD -51.286%
Prenetics Global Limited -52.51 Million USD 21.274%
Illumina, Inc. -1.06 Billion USD 96.133%
DarioHealth Corp. -56.18 Million USD 26.423%
ENDRA Life Sciences Inc. -10.52 Million USD -292.957%
Medpace Holdings, Inc. 336.82 Million USD 112.274%
Mainz Biomed B.V. -26.64 Million USD -55.16%
Trinity Biotech plc -27.04 Million USD -52.864%
Sotera Health Company 276.69 Million USD 114.942%
bioAffinity Technologies, Inc. -7.97 Million USD -418.51%